BQM-31825-41301
2 vaccinations
5 coded responses
25 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 730 / OK
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Pfizer-BioNTech
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-04
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-07
Health check-in — day 7, dose 1Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-07
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
-
2021-01-21
Survey response — day 21, dose 1MedDRA: Headache, Migraine, Nausea, Vomiting — Feeling: Fair · Be unable to do your normal daily activitiesFree text: 2 Migraines, common with my female monthly cycles. Nausea both times excruciating headache pain and 1 time vomiting.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Dose 2 — Pfizer-BioNTech
- 2021-01-22
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-02-05
-
2021-02-12
Survey response — day 21, dose 2MedDRA: Back pain, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Low back pain and snifflesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Survey response — day 28, dose 2MedDRA: Fatigue, Oropharyngeal pain, SARS-CoV-2 test false negative, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, sneezing, and fatigue. Potentially allergy related started experiencing symptoms on Thursday Feb 18th. My city has had major weather shut downs and road closures, or I would have done Covid test. if symptoms persist, i will test Monday.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
- 2021-03-05
-
2021-04-23
Survey response — 3 months, dose 2MedDRA: Hyperacusis, Migraine, Nausea, Photophobia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Migraines, which were a norm for me prior to the vaccine. Migraines are always left side temple pain and cause me to be both light and sound sensitive and are often accompanied with nausea. Not exactly new, but ongoing at least one to two times/mon.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-24
-
2022-01-24
Survey response — 12 months, dose 2MedDRA: Diarrhoea — Feeling: GoodFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech |
Call center
2 call center cases
2 priority 2/3 (triaged and no follow up)
Free text
Release 2 — day 21, dose 1
Symptoms: 2 Migraines, common with my female monthly cycles. Nausea both times excruciating headache pain and 1 time vomiting.
Release 4 — day 21, dose 2
Symptoms: Low back pain and sniffles
Release 4 — day 28, dose 2
Symptoms: Sore throat, sneezing, and fatigue. Potentially allergy related started experiencing symptoms on Thursday Feb 18th. My city has had major weather shut downs and road closures, or I would have done Covid test. if symptoms persist, i will test Monday. cut off by CDC
Release 7 — 3 months, dose 2
Symptoms: Migraines, which were a norm for me prior to the vaccine. Migraines are always left side temple pain and cause me to be both light and sound sensitive and are often accompanied with nausea. Not exactly new, but ongoing at least one to two times/mon. cut off by CDC
Release 11 — 12 months, dose 2
Symptoms: Diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hyperacusis | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Photophobia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test false negative | ○ | ✓ | ○ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release